金山軟件(03888.HK):金山雲集團預計一季度收入增加59.6%至65.5%
格隆匯4月28日丨金山軟件(03888.HK)公佈,於2020年4月28日,金山雲遵照美國1933年證券法(經修訂)就金山雲發售向美國證交會公開提交其註冊聲明的第1項修訂。
經更新註冊聲明載有金山雲及其附屬公司截至2020年3月31日止3個月的若干估計初步未經審核節選財務數據。據估計,金山雲集團截至2020年3月31日止3個月的收入人民幣13.5億元至人民幣14億元,同比增加59.6%至65.5%,主要是由於金山雲集團的公開雲服務及企業雲服務業務均實現增長;金山雲集團期間毛利率不低於上年同期的毛利率4.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.